If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Laura Ferrari is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Breast Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
exemestane Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2018

  • 1861 Citations
  • 17 h-Index
  • 47 Article
  • 1 Chapter
  • 1 Comment/debate
  • 1 Review article

Bone metastases in biliary cancers: A multicenter retrospective survey

Santini, D., Brandi, G., Aprile, G., Russano, M., Cereda, S., Leone, F., Lonardi, S., Fornaro, L., Scartozzi, M., Silvestris, N., Barni, S., Pantano, F., Vincenzi, B., Palloni, A., Frega, G., Casagrande, M., Ferrari, L., Dadduzio, V., Intini, R., Filippi, R. & 7 others, Vasile, E., Vivaldi, C., Faloppi, L., Brunetti, O., Reni, M., Aglietta, M. & Tonini, G., Sep 2018, In : Journal of Bone Oncology. 12, p. 33-37 5 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Bone Neoplasms
Diphosphonates
Neoplasm Metastasis
Bone and Bones

Erratum to: Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemotherapy (The Oncologist, (2017), 22, 12, (1463-1469), 10.1634/theoncologist.2017-0158)

Fanotto, V., Uccello, M., Pecora, I., Rimassa, L., Leone, F., Rosati, G., Santini, D., Giampieri, R., Di Donato, S., Tomasello, G., Silvestris, N., Pietrantonio, F., Battaglin, F., Avallone, A., Scartozzi, M., Lutrino, E. S., Melisi, D., Antonuzzo, L., Pellegrino, A., Ferrari, L. & 8 others, Bordonaro, R., Vivaldi, C., Gerratana, L., Bozzarelli, S., Filippi, R., Bilancia, D., Russano, M. & Aprile, G., Feb 1 2018, In : Oncologist. 23, 2, 1 p.

Research output: Contribution to journalComment/debate

Medical Oncology
Italy
Stomach Neoplasms
Publications
Drug Therapy
1 Citation (Scopus)

Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience

Pizzuti, L., Giordano, A., Michelotti, A., Mazzotta, M., Natoli, C., Gamucci, T., De Angelis, C., Landucci, E., Diodati, L., Iezzi, L., Mentuccia, L., Fabbri, A., Barba, M., Sanguineti, G., Marchetti, P., Tomao, S., Mariani, L., Paris, I., Lorusso, V., Vallarelli, S. & 30 others, Cassano, A., Airoldi, F., Orlandi, A., Moscetti, L., Sergi, D., Sarobba, M. G., Tonini, G., Santini, D., Sini, V., Veltri, E., Vaccaro, A., Ferrari, L., De Tursi, M., Tinari, N., Grassadonia, A., Greco, F., Botticelli, A., La Verde, N., Zamagni, C., Rubino, D., Cortesi, E., Magri, V., Pomati, G., Cazzaniga, M., Mancini, M., Carpano, S., De Maria, R., Sperduti, I., Ciliberto, G. & Vici, P., Jan 1 2018, (Accepted/In press) In : Journal of Cellular Physiology.

Research output: Contribution to journalArticle

exemestane
Confidence Intervals
Breast Neoplasms
Toxicity
Therapeutics
8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients

Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 20 others, Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L., Torri, V., of, O. B. & Gervasi, E., Oct 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

exemestane
Epidermal Growth Factor
Hormones
Breast Neoplasms
Safety
8 Citations (Scopus)

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cazzaniga, M. E., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V. & 19 others, Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L., Torri, V. & on behalf of, Oct 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

exemestane
Extravehicular Activity
Epidermal Growth Factor
Clinical Trials
Hormones